Cibus announces pricing of $27.5 million public offering
Source: SeekingAlpha
2025-06-05 09:44:48 ET
More on Cellectis, Cibus
- Cellectis: Partnerships And Promised Data In 2025 Continue To Justify The Buy
- Tootsie Roll among names set to join Russell 3000 Index, Growgeneration, Veru set to leave
- Cellectis Non-GAAP EPS of -$0.17, revenue of $12M misses by $1.83M
Read the full article on Seeking Alpha
For further details see:
Cibus announces pricing of $27.5 million public offering
Cellectis Romainville Ord
NASDAQ: CMVLF
CMVLF Trading
44900.0% G/L:
$4.50 Last:
2,000 Volume:
$4.50 Open:
CMVLF Latest News
March 12, 2026 04:30:00 pm
Cellectis to Report Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026
December 08, 2025 01:30:00 am
ASH 2025: Cellectis Presents Development Plan to Further Enhance High Response Rate Observed for Eti-cel in r/r NHL
CMVLF Stock Data
$268,189,208
45,874,895
N/A
58
N/A
Biotechnology & Life Sciences
Healthcare
FR
Paris
